|
Market Closed -
Hong Kong S.E.
04:08:21 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 1.055 HKD | 0.00% |
|
-1.86% | -30.59% |
| 09-10 | Lee's Pharma Licenses Cancer Drug OC-3 From 1cBio; Shares Plummet 4% | MT |
| 08-31 | Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Company Valuation: Lee's Pharmaceutical Holdings Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 2,764 | 1,961 | 959.8 | 900.9 | 836.1 | 895 |
| Change | - | -29.06% | -51.05% | -6.13% | -7.19% | 7.04% |
| Enterprise Value (EV) 1 | 2,506 | 1,950 | 934 | 934.1 | 846.6 | 855.4 |
| Change | - | -22.18% | -52.11% | 0.01% | -9.36% | 1.04% |
| P/E | 21.4x | 0.99x | 18.7x | 54x | 8.98x | 9.74x |
| PBR | 1.29x | 0.8x | 0.5x | 0.44x | 0.51x | 0.44x |
| PEG | - | 0x | -0.2x | -0.8x | 0x | -7.7x |
| Capitalization / Revenue | 2.27x | 1.55x | 0.78x | 0.86x | 0.6x | 0.62x |
| EV / Revenue | 2.06x | 1.54x | 0.76x | 0.89x | 0.6x | 0.6x |
| EV / EBITDA | 13.9x | 116x | 3.93x | 7.15x | 3.84x | 4.32x |
| EV / EBIT | 36.7x | -20.5x | 7.33x | 25.9x | 6.34x | 7.76x |
| EV / FCF | -8.6x | -11x | 13.6x | -20.8x | 17.1x | 29.9x |
| FCF Yield | -11.6% | -9.12% | 7.38% | -4.81% | 5.86% | 3.35% |
| Dividend per Share 2 | 0.058 | 0.061 | 0.02 | 0.018 | 0.045 | 0.045 |
| Rate of return | 1.23% | 1.83% | 1.23% | 1.18% | 3.17% | 2.96% |
| EPS 2 | 0.2199 | 3.374 | 0.0871 | 0.0284 | 0.1581 | 0.1561 |
| Distribution rate | 26.4% | 1.81% | 23% | 63.5% | 28.5% | 28.8% |
| Net sales 1 | 1,217 | 1,266 | 1,233 | 1,053 | 1,400 | 1,436 |
| EBITDA 1 | 179.9 | 16.83 | 237.9 | 130.6 | 220.3 | 198 |
| EBIT 1 | 68.38 | -95.13 | 127.4 | 36.04 | 133.6 | 110.3 |
| Net income 1 | 129.3 | 1,987 | 51.28 | 16.7 | 93.1 | 91.94 |
| Net Debt 1 | -257.8 | -10.39 | -25.81 | 33.14 | 10.45 | -39.63 |
| Reference price 2 | 4.700 | 3.330 | 1.630 | 1.530 | 1.420 | 1.520 |
| Nbr of stocks (in thousands) | 588,125 | 588,835 | 588,835 | 588,835 | 588,835 | 588,835 |
| Announcement Date | 4/21/21 | 4/21/22 | 4/21/23 | 3/26/24 | 4/23/25 | 4/23/26 |
1HKD in Million2HKD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 79.18M | |
| 37.84x | 13.27x | 28.43x | 0.53% | 1,148B | |
| 39.67x | 6.67x | 18.75x | 1.97% | 652B | |
| 37.4x | 8.39x | 17.35x | 2.4% | 505B | |
| 21.45x | 5.21x | 12.93x | 2.51% | 384B | |
| 102.73x | 5.76x | 24.72x | 2.42% | 348B | |
| 21.89x | 5.76x | 13.88x | 2.85% | 294B | |
| 22.21x | 4.49x | 12.82x | 1.97% | 264B | |
| 28.66x | 7.33x | 13.12x | 2.23% | 244B | |
| -45.79x | 7.11x | 27.55x | 2.07% | 197B | |
| Average | 29.56x | 7.11x | 18.84x | 2.11% | 403.72B | |
| Weighted average by Cap. | 35.29x | 8.40x | 20.64x | 1.79% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 950 Stock
- Valuation Lee's Pharmaceutical Holdings Limited
Select your edition
All financial news and data tailored to specific country editions
